Free Guide: The evolving landscape of EGFR in NSCLC

EGFR exon 20 insertions represent a subset of EGFR-mutant lung cancer and are a heterogeneous group of mutations. Conventional PCR methods can miss EGFR exon 20 insertions, thus molecular profiling with next-generation sequencing (NGS) technology enables precise identification and characterization of exon 20 insertions in clinical research. Download this guide to learn more about the evolving landscape of EGFR in NSCLC.

First Name

Last Name

Name of Institution

Telephone

City

Postal code/Zip

Are you interested in receiving a demo about the Oncomine NGS Assays and Genexus NGS System for EGFR exon 20 insertion biomarker testing in clinical research?

Yes

I would like Thermo Fisher Scientific (including its affiliates) to add me to a list to receive information events, products, services and promotions which Thermo Fisher believes may be of interest to me via the following channels:

Phone

I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com
I acknowledge Thermo Fisher Scientific (including its affiliates) will process my Personal Information according to its Privacy Policy, which includes information about my rights.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.